Xenon Pharmaceuticals Inc. Stock
Xenon Pharmaceuticals Inc. gained 1.490% today.
The community is currently still undecided about Xenon Pharmaceuticals Inc. with 1 Buy predictions and 1 Sell predictions.
As a result the target price of 50 € shows a positive potential of 22.55% compared to the current price of 40.8 € for Xenon Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Xenon Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Xenon Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xenon Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | 1.490% | 8.511% | 5.699% | 11.475% | 0.493% | - | - |
| Promis Neurosciences Inc. | -4.600% | -1.775% | -15.306% | -72.562% | 66.834% | -75.298% | -82.708% |
| InMed Pharmaceuticals Inc. | -2.650% | 8.163% | -28.593% | -76.754% | -30.669% | -99.688% | -99.902% |
| Resverlogix Corp | - | -1.351% | 10.606% | -60.109% | -15.116% | -94.016% | -98.608% |